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ABSTRACT Blebbistatin is a small-molecule, high-afﬁnity, noncompetitive inhibitor of myosin II. We have used negative staining
electronmicroscopy tostudy theeffectsof blebbistatinon theorganizationof themyosinheadsonmuscle thick ﬁlaments. LossofADP
and Pi from the heads causes thick ﬁlaments to lose their helical ordering. In the presence of 100 mMblebbistatin, disordering was at
least 10 times slower. In theMADPstate,myosin heads are also disordered.Whenblebbistatinwas added toMADP thick ﬁlaments,
helical orderingwas restored. However, blebbistatin did not improve the order of thick ﬁlaments lacking bound nucleotide. Addition of
calcium to relaxed muscle homogenates induced thick-thin ﬁlament interaction and ﬁlament sliding. In the presence of blebbistatin,
ﬁlament interaction was inhibited. These structural observations support the conclusion, based on biochemical studies, that
blebbistatin inhibits myosin ATPase and actin interaction by stabilizing the closed switch 2 structure of the myosin head. These
properties make blebbistatin a useful tool in structural and functional studies of cell motility and muscle contraction.
INTRODUCTION
Blebbistatin is a small-molecule, high-afﬁnity, noncompeti-
tive inhibitor speciﬁc formost forms ofmyosin II. It derives its
name from its ability to inhibit cell blebbing by interfering
with nonmusclemyosin II function (1). In addition to its effect
on nonmuscle myosin, blebbistatin has also been found to
inhibit several striated muscle myosins (2,3) and some types
of smooth muscle myosin (2,4), but to have no effect on un-
conventional myosins (2). The molecule binds at the apex of
the 50 kDa cleft of the myosin head, close to the g-phosphate
pocket of the ATP binding site (5). In so doing, it appears to
slow Pi release from the heads, prolonging the MADPPi
state by stabilizing the switch 2 closed structure of the nu-
cleotide binding pocket (5–7). Stabilization of the MADPPi
state, by preventing complete closure of the 50 kDa cleft, is
thought to keep themyosin head in aweak actin-binding state,
preventing completion of the actomyosin crossbridge cycle
and thus inhibiting motility. These properties have made
blebbistatin a useful molecule for cellular and molecular
studies involving myosin II function. For example, cell ac-
tivities requiring myosin II can be detected by their inhibition
by blebbistatin (1,8,9). In muscle studies, blebbistatin is
valuable as an uncoupler of excitation-contraction coupling in
electrophysiological studies (10). Here we complement pre-
vious biochemical observations of blebbistatin (2,6,7) by
studying its structural effects on nativemyosin ﬁlaments from
muscle and its consequent utility as a tool in structural studies
of myosin.
In muscle, myosin II molecules are assembled into ﬁla-
ments (the ‘‘thick’’ ﬁlaments) (11,12) that interact with actin
(‘‘thin’’) ﬁlaments to generate contraction (13). In nonmuscle
cells, myosin II transiently forms ﬁlaments that interact with
actin to generate many forms of cell motility (14–16). The
thick ﬁlaments of diverse relaxed muscles are all character-
ized by helical ordering of their surface array of myosin heads
(12,17–29). This ordered structure is lost onmuscle activation
or when myosin heads lose their ATP (17,30–32). Helical
ordering appears to require the closing of switch 2 of the
nucleotide binding site on the myosin head (33,34), which
prevents Pi release. In this statemyosin heads are sharply bent
(35) and undergo intramolecular head-head interactions (36–
38). In intrinsically regulated myosins (those regulated by
phosphorylation of the regulatory light chain or Ca21 binding
to the essential light chain), these interactions appear to switch
off myosin activity, leading to relaxation (36,37,39–41).
Similar interactions are also present in unregulated ﬁlaments
(38).
Our greatest insights into thick ﬁlament structure and
function have come from studies of tarantula ﬁlaments, whose
stable helical ordering has made them an excellent model
system for structural studies (20,37,42). In this study we used
tarantula ﬁlaments to study blebbistatin’s effects on ﬁlament
structure. Our observations support previous biochemical
data suggesting that blebbistatin stabilizes the closed switch 2
state of the myosin head, inhibiting Pi release, ATPase ac-
tivity, and actin binding. The results show that it is a useful
tool for stabilizing the helical ordering of myosin heads in
labile ﬁlaments, improving the detail visible in structural
studies (38), and for stabilizing head-head interaction in
weakly interacting structures (41). Our observations also
show directly that blebbistatin inhibits actin-myosin binding,
which has proved to be important for separating thick and thin
ﬁlaments in ﬁlament studies (38).
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MATERIALS AND METHODS
Solutions
Rigor solution consisted of 100mMNaCl, 3mMMgCl2, 1mMEGTA, 5mM
PIPES, and 1 mM NaN3, pH 7.0. Relaxing solution was rigor solution con-
taining 1 mMMgATP. Rigor rinse contained 100 mM NaAc, 3 mMMgCl2,
0.2mMEGTA,2mMimidazole, and1mMNaN3, pH7.0.Relaxing rinsewas
rigor rinse containing 1 mM MgATP, and ADP rinse was rigor rinse con-
taining 1 mM MgADP, 100 mM AP5A, 0.1 mg/mL hexokinase, and 1 mM
glucose (see below).
Preparation of thick ﬁlaments
Relaxed, native thick ﬁlaments were puriﬁed from saponin-skinned tarantula
leg muscle according to Hidalgo et al. (43), except that the Ca21-insensitive
gelsolin fragment used to fragment the thin ﬁlaments was obtained by bacterial
expression (44).
Effect of different nucleotide states on thick
ﬁlament structure
ATP removal
Puriﬁed thick ﬁlaments in relaxing solution were centrifuged at 18,0003 g for
20 min, resuspended in rigor solution containing 100 mM AP5A, 0.1 mg/mL
hexokinase, and 1 mMglucose, and then incubated at room temperature for 30
min to remove any residual ATP. This process was repeated twicemore in rigor
solution (without added AP5A, hexokinase, and glucose). The ﬁnal suspension
contained thick ﬁlaments in rigor solution. The heads in these ﬁlaments would
be in the apo state.
Time course of structural change as ADP and Pi dissociate
from the myosin heads
Puriﬁed thick ﬁlaments were resuspended in relaxing solution, and apyrase
(Sigma A6535) was added to a ﬁnal concentration of 16 units/mL. This
would hydrolyze all ATP and ADP in solution in less than 1 min.
Presence of ADP
Rigor thick ﬁlaments were prepared as described under ‘‘ATP removal’’ and
resuspended in rigor solution containing 1 mM MgADP. The solution also
contained AP5A and hexokinase (as above) to remove contaminating ATP
from the ADP, and AP5A (100 mM) to inhibit conversion of ADP to ATP by
contaminating adenylate kinase. This reduces ATP levels to ,1 mM in 20
min (33).
The effects of blebbistatin on the structures observed in these conditions
were studied by adding blebbistatin (EMD, Darmstadt, Germany) to the ﬁl-
ament suspensions at a ﬁnal concentration of 100 mM. Experiments were
carried out in covered tubes to avoid light inactivation of blebbistatin (45).
Electron microscopy and image analysis
A6-mLdrop of ﬁlament suspensionwas applied to a 400-mesh grid coatedwith
a thin carbon ﬁlm supported by a holey carbon ﬁlm. The grid was then rinsed
with three to four drops of the appropriate acetate-based rinsing solution (20),
and negatively stained with 1% (w/v) uranyl acetate. Drying was performed at
;80% relative humidity (46). Conventional dose images of negatively stained
specimenswere recorded at 15,5003magniﬁcation onKodak4489ﬁlmusing a
Philips (FEI, Hillsboro, OR) CM10 electronmicroscope operated at 80 kV. For
image processing, ﬁlms were scanned on a FlexTight scanner at a pixel size of
1.1 nm in the original specimen. Fourier transforms of boxed areas of selected
ﬁlaments were computed and averaged using ImageJ (v1.34s, NIH, Bethesda,
MD). Averaged Fourier transforms in Figs. 1–5 (from 40, 20, 20, 20, and 10
ﬁlament segments, all of the same length, respectively) were brightness- and
FIGURE 1 Effects of different nucleotides on helical
ordering of myosin heads. (a, Top) tarantula thick ﬁlament
negatively stained in relaxing conditions (MADPPi state),
showing helical ordering of myosin heads. Ordering along
helical tracks is most apparent when viewing along the
ﬁlament axis at a glancing angle, and is conﬁrmed by the
appearance of layer lines at orders of 43.5 nm in averaged
Fourier transform (bottom). (b) Filament negatively stained
after removal of solution ATP and allowing time for ADP
and Pi to dissociate (apo state). Heads are disordered and
project away from the ﬁlament backbone (compare with the
compact structure of a); the averaged Fourier transform
lacks signiﬁcant layer lines, conﬁrming disorder. (c) Fila-
ment negatively stained in the presence of MgADP
(MADP state). The ﬁlament image and averaged Fourier
transform show disorder. Weak meridional reﬂections at the
6th order (7.2 nm) of the 43.5 nm repeat in (b) and (c)
probably originate from the ﬁlament backbone, which is
more exposed in the disordered ﬁlaments. Averaged trans-
forms in a–c are from 40 ﬁlament segments, all of the same
length.
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contrast-adjusted to show a clear signal; adjustments for each condition were
identical so that the transforms could be objectively compared.
RESULTS
Myosin heads lose their relaxed helical order in
MADP and apo states
Relaxed thick ﬁlaments (MADPPi state) showed clear helical
ordering of the myosin heads when visualized by negative
staining (Fig. 1 a), as found in previous studies (20,42). This was
conﬁrmed by the presence of strong layer lines in their Fourier
transforms, which extended to at least the sixth order of the basic
43.5 nm helical repeat. The ﬁrst and fourth off-meridional layer
lines and the third and sixthmeridional layer lineswere all strong,
with weaker reﬂections on the second and ﬁfth layer lines (Fig.
1 a) (20,42). Filaments in which all nucleotide had dissociated
from the heads (apo state) appeared completely disordered, both
by eye and from the absence of layer lines in their Fourier
transforms (Fig. 1 b) (30–32). Filaments in which MgADP, but
not Pi, was present on the heads (MADP state) were also dis-
ordered (Fig. 1 c). These controls conﬁrm earlier studies (33).
Blebbistatin inhibits Pi release from
myosin heads
We determined the effect of blebbistatin binding to the my-
osin heads on the maintenance of the ordered state after re-
moval of ATP and ADP from a relaxed thick ﬁlament
suspension. Puriﬁed thick ﬁlaments in relaxing solution
(containing 1 mMMgATP) were divided into three aliquots:
1), an untreated control; 2), the same as the control but con-
FIGURE 2 Blebbistatin maintains head ordering in the
absence of free nucleotide. (a–h) Time points at 0, 5, 60,
and 90 min after treatment of thick ﬁlament suspension with
apyrase (to remove ATP and ADP from solution) in the
absence (a–d) and presence (e–h) of 100 mM blebbistatin.
Average Fourier transforms of ﬁlaments conﬁrm visual
impression of order or disorder. Helical order is retained for
at least 1 h in the presence of blebbistatin, but is lost in its
absence. At 90 min (d and h) and 120 min (not shown), only
the 43.5 and 14.5 nm reﬂections are prominent, showing
that over long time periods helical order weakens even in
the presence of blebbistatin.
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taining apyrase (16 units/mL) to hydrolyze ATP and ADP in
solution; and 3), the same as aliquot 2 but also containing
blebbistatin (100 mM). Filaments from each aliquot were neg-
atively stained at different times during a 2-h room-temperature
incubation.
Relaxing solution control
The control in relaxing solution retained the helical order of the
myosin heads throughout the 2-h period, as judged by both the
visual appearance of the ﬁlaments and the layer lines in their
Fourier transforms (cf., Fig. 1 a). Dissociation of ADP and Pi
during this time would have been followed immediately by
rebindingofATP fromsolution, followedbyhydrolysis toADP
and Pi, thus maintaining the relaxed helical structure (20,33).
Treatment with apyrase
When ﬁlaments were incubated with apyrase at room tem-
perature, they appeared fully ordered at 0 min (Fig. 2 a), but
had lost their order within 5 min (Fig. 2 b), an appearance that
continued through 60 min (Fig. 2 c) and beyond (Fig. 2 d).
Fourier transforms showed little or no sign of myosin layer
lines. Here, ATP and ADP present in solution are rapidly
hydrolyzed (,1 min) by apyrase. Thus, when bound Pi and
ADP are released from the myosin heads, they would not be
replaced, and the heads would go into the apo state, causing
disorder (cf., Fig. 1 b). Our observations suggest that this
happens within 5 min (Fig. 2 b).
Treatment with apyrase in the presence of blebbistatin
When the same experiment was performed in the presence of
blebbistatin, the helical order appeared excellent in most ﬁla-
ments, even at 60 min, and this was conﬁrmed by the persis-
tence of layer lines similar to those in relaxing conditions (Fig.
2 e–g). With longer times (up to 2 h), ﬁlaments started to lose
their order and their helical layer lines became weaker, even in
the presence of blebbistatin (Fig. 2 h), but this effect was small
andmore than an order ofmagnitude slower than in its absence.
Our results thus show that in the presence of 100 mM
blebbistatin, disordering of thick ﬁlaments is slowed at least
10-fold, consistent with biochemical studies (6). Because the
MADPPi state promotes helical ordering (33,47), this is
consistent with blebbistatin acting as an inhibitor of Pi release
from the nucleotide pocket.
FIGURE 3 Blebbistatin restores helical order to disordered MADP thick
ﬁlaments. (a) In rigor solution containing 1 mM MgADP, heads are dis-
ordered and project away from the ﬁlament backbone. (b) After treatment
with blebbistatin, helical ordering is restored.
FIGURE 4 Blebbistatin does not restore order to apo thick ﬁlaments. (a)
Under rigor conditions, in which all ATP and ADP have been removed from
solution, and all bound nucleotide has had time to dissociate, myosin heads
are disordered and project away from the ﬁlament backbone. (b) Treatment
with blebbistatin fails to restore helical ordering to such rigor ﬁlaments.
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Blebbistatin reorders MADP thick ﬁlaments
Having shown that blebbistatin prolongs the ordered state of
myosin ﬁlaments after removal of nucleotide, we wanted to
determine whether it could also restore order to disordered
ﬁlaments. Apo ﬁlaments were suspended in rigor solution
containing 1 mM MgADP (see Materials and Methods).
Under these conditions (MADP state), the myosin heads
appeared fully disordered, and this was conﬁrmed by the
absence of layer lines in their Fourier transforms (Fig. 3 a).
Thus MgADP alone fails to restore order to apo ﬁlaments,
conﬁrming earlier ﬁndings (33). However, when 100 mM
blebbistatin was included with the MgADP solution, the
disorderedMADP ﬁlaments became ordered again (Fig. 3 b).
The same result was obtained whether blebbistatin was added
before, after, or together with the MgADP. The ordering and
the layer line pattern to which it gave rise were indistin-
guishable from those of relaxed ﬁlaments (compare Figs. 1 a
and 3 b). Based on earlier studies (33,34), we conclude that
blebbistatin promotes the closing of switch 2 of the nucleo-
tide binding site when ADP is present.
Blebbistatin does not reorder rigor
thick ﬁlaments
Since blebbistatin can reorder disordered ﬁlaments in the
MADP state, we next tested its ability to restore order to apo-
state ﬁlaments. Thickﬁlaments in rigor conditions consistently
showed disorder of themyosin heads (Figs. 1 b and 4 a). There
was no return of order after incubation with 100 mM bleb-
bistatin (Fig. 4b). Thusblebbistatin does not reorder nucleotide-
free heads on thick ﬁlaments.
Blebbistatin inhibits thick-thin
ﬁlament interaction
We also determined whether blebbistatin has an inhibitory ef-
fect on actin-myosin interaction. At high concentration, un-
puriﬁed homogenates of tarantula muscle (containing native
thick and thin ﬁlaments) have a turbid appearance in relaxing
conditions. When viewed by electron microscopy, thick and
thin ﬁlaments are seen to be separate from each other, with only
occasional interactions, and the thick ﬁlaments are ordered
(Fig. 5 a) (20). On addition of;0.4 mM free Ca21 to the ho-
mogenate there was an immediate visual ‘‘granulation’’ of the
suspension and adherence of granularmaterial to thewall of the
tube, as reported previously (48). Negative stain images re-
vealed numerous thick-thin ﬁlament interactions (Fig. 5 b) and
often large ﬁlament bundles, consistent with this macroscopic
appearance. The thick ﬁlaments were generally disordered
(30). In the presence of 100 mM blebbistatin, these Ca21-in-
duced changeswere absentmacroscopically, andnegative stain
images showed separate thick and thin ﬁlaments, with the thick
ﬁlaments retaining their helical order (Fig. 5 c). These results
show that blebbistatin inhibits actin-myosin interaction.
DISCUSSION
Our observations on nativemyosin ﬁlaments demonstrate that
blebbistatin slows the rate of disordering of myosin heads
FIGURE 5 Inhibition of thick-thin ﬁlament interaction
by blebbistatin. (a) Relaxed muscle homogenate containing
thick and thin ﬁlaments showing very few interactions.
Thick ﬁlaments reveal helical order by eye and in the
averaged Fourier transform. (b) When a relaxed muscle
homogenate containing thick and thin ﬁlaments is activated
by Ca21, numerous densely stained ﬁlament aggregates are
formed, suggesting thick-thin ﬁlament interaction. These
aggregates are difﬁcult to image due to the density of
staining. Smaller aggregates, like the one shown, reveal
many ﬁlament interactions and a generally disordered array
of heads. (c) When treated with Ca21 in the presence of
blebbistatin, thick and thin ﬁlaments show minimal inter-
action with each other, aggregates are absent, and the heads
have a degree of helical ordering similar to that of relaxed
ﬁlaments (compare the transform with that in a).
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after removal of ATP, reorders the disordered array of heads
occurring in the MADP state (but not the disorder of the apo
state), and inhibits actin-myosin interaction occurring in an
activated ﬁlament preparation. These structural observations,
together with previous ﬁndings on the requirements for thick
ﬁlament order (33,34), directly support earlier studies that
found that blebbistatin stabilized the closed state of the switch
2 element of the nucleotide binding site (5,6). In this state, in
which both ADP and Pi are bound in the active site, myosin
binds only weakly to actin. These earlier studies were based
on enzyme kinetics, x-ray crystallography, and observations
of actin motility in the presence of blebbistatin (2,5–7). Our
results reveal the structural manifestations of blebbistatin in-
hibition thatwould occur in the thickﬁlaments in intactmuscle.
Our observations are consistent with previous ﬁndings on
the selectivity of blebbistatin, showing that it inhibits a variety
of myosin II species (but not unconventional myosins) from
nonmuscle, striated muscle, and some smooth muscle sources
(2,4). The ﬁnding that blebbistatin inhibits tarantula (this study)
as well as scallop (2) striated myosins, regulated by phospho-
rylation of the regulatory light chain (30) and Ca21 binding to
the essential light chain (49,50), respectively, suggests that it
is likely to inhibitmost types of invertebrate striatedmyosin IIs.
Recent studies of tarantula and rabbit striated muscle thick
ﬁlaments have revealed that helical ordering of the heads re-
quires the closed switch 2 state (33,34). Our observation that
blebbistatin stabilizes helical ordering therefore suggests that
it promotes the closing of switch 2. Helical ordering has been
shown to involve intramolecular interaction between myosin
heads (37), the actin-binding region of one head binding to the
converter and essential light chain of the other (36,37,39).
Stabilization of helical ordering thus suggests that head-head
interaction is likewise favored by blebbistatin. This has been
shown to be the case in single-molecule studies of myosin
(41). When switch 2 is closed, myosin binds only weakly to
actin (51), which would explain the inhibition of thick-thin
ﬁlament interaction that we observe in activated ﬁlament
preparations.We conclude that whenmuscles are treated with
blebbistatin, their thick ﬁlaments become stabilized in an
‘‘enhanced’’ relaxed state, with their heads in stable helical
arrays, interacting with each other but not with actin, even
under activating conditions.
Our conclusions are consistent with x-ray diffraction data
from rabbit psoas muscle treated with blebbistatin (52,53).
Blebbistatin enhanced the strength of layer lines already pres-
ent in x-ray patterns of relaxed muscle, and induced layer lines
in conditions in which they were otherwise absent (MgADP or
absence of nucleotide). It was concluded that blebbistatin shifts
the equilibrium of the myosin head toward the switch 2 closed
state. The detection of weak reordering in rigor ﬁlaments,
which was not observed in our studies, may reﬂect the aver-
aging of large numbers of ﬁlaments that occurs with x-ray
diffraction, making possible the detection of small changes.
These properties of blebbistatin make it an excellent tool in
studies of myosin II. Functional studies, in which inhibition by
blebbistatin has been used to determine the role of myosin II in
different cell processes, were referred to earlier (1,8,9).
Blebbistatin has also been used, for example, as an uncoupler
of excitation-contraction coupling, making it possible to carry
out ﬂuorescence imaging of electrical activity inmuscle while
avoidingmotion artifacts (10). Blebbistatin has also proved to
be an invaluable tool for muscle structural studies. Its ability
to promote the relaxed helical ordering of themyosin heads on
the thick ﬁlament backbone helped in the isolation of verte-
brate cardiac thick ﬁlaments (38) by minimizing thick-thin
ﬁlament interactions, which are common in cardiac ﬁlament
preparations, even under relaxing conditions (28). In the same
work (38), blebbistatin also played a crucial role in stabilizing
the helical array of myosin heads on the ﬁlament surface,
which is labile and easily disrupted in mammals. This made
possible the most detailed three-dimensional reconstruction
of vertebrate thick ﬁlaments yet available, revealing new
features of myosin head organization (38). The use of bleb-
bistatin in structural studies of the more stable vertebrate
skeletal thick ﬁlament may also be of great value.
Invertebrate thick ﬁlaments, regulated by regulatory light
chain phosphorylation or Ca21 binding to the essential light
chains, are intrinsically well ordered (19,20,23,24) and have
been the source of ourmost detailed insights so far intomyosin II
ﬁlament structure (37). The use of blebbistatin to further en-
hance invertebrate ﬁlament order may improve the resolution
even more. In studies of single myosin molecules, it has been
shown that myosin heads interact with each other intramo-
lecularly in the inactive (switched-off) state (36,39,40). As is
the case with ﬁlaments, this interaction is relatively stable in
regulated myosins, but much weaker in unregulated (verte-
brate striated) myosin (41). Thus only a small number of
vertebrate molecules show a head-head interaction, making
image averaging difﬁcult. By stabilizing the switch 2 closed
structurewith blebbistatin, the number ofmolecules that show
interacting heads increases dramatically, providing structural
insights that are otherwise inaccessible (41).
Blebbistatin might also prove valuable in x-ray crystallo-
graphic studies of myosin. Although myosin heads have been
crystallized in numerous studies, leading to many new insights
into their function (35,54,55), attempts to crystallize myosin in
its functional, two-headed form have not been successful. A
likely difﬁculty is motion of the heads about their junctionwith
themyosin tail. Blebbistatin shouldhelp tominimizemotionby
favoring the closing of switch 2 and thus formation of the more
rigid structure in which the heads interact with each other.
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